• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vor Biopharma Inc (NQ: VOR )

0.7710 -0.0090 (-1.15%)
Streaming Delayed Price Updated: 10:06 AM EST, Nov 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vor Biopharma Inc

< Previous 1 2 3 4 5 Next >
12 Health Care Stocks Moving In Monday's After-Market Session
September 30, 2024
Via Benzinga
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer
September 30, 2024
From Vor Biopharma
Via GlobeNewswire
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
September 10, 2024
Via Benzinga
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
September 06, 2024
Vor Biopharma reveals promising Phase 1/2 study results for AML treatment, and it is planning FDA pivotal trial discussions. 
Via Benzinga
Exposures Product Safety
Vor Biopharma: Q4 Earnings Insights
March 20, 2024
Via Benzinga
Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
September 06, 2024
Via Benzinga
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
September 05, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
August 28, 2024
From Vor Biopharma
Via GlobeNewswire
VOR Stock Earnings: Vor Biopharma Beats EPS for Q2 2024
August 09, 2024
VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Vor Bio Reports Second Quarter 2024 Financial Results and Provides Company Update
August 08, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 09, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 04, 2024
From Vor Biopharma
Via GlobeNewswire
VOR Stock Earnings: Vor Biopharma Beats EPS for Q1 2024
May 09, 2024
VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
May 09, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
May 06, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
May 02, 2024
From Vor Biopharma
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via Benzinga
Vor Bio to Participate in Upcoming Investor Conferences
April 01, 2024
From Vor Biopharma
Via GlobeNewswire
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
March 28, 2024
Although speculation can be bad for your blood pressure, these compelling penny stocks have some strong endorsements. 
Via InvestorPlace
VOR Stock Earnings: Vor Biopharma Beats EPS for Q4 2023
March 20, 2024
VOR stock results show that Vor Biopharma beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
March 20, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in Upcoming Investor Conferences
March 04, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
January 17, 2024
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 21, 2023
From Vor Biopharma
Via GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From Vor Biopharma
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap